Therefore, CNR1 gene polymorphisms may influence CB1R signaling in podocytes and result in CB1 receptor activation either directly or indirectly (through its metabolic ramifications) by enhancing diabetes-related inflammation and ROS generation, encouraging tissue injury, and promoting the emergence of diabetic complications. Here, CNR1 is linked to diabetes mellitus.